When Will TherapeuticsMD, Inc. (NASDAQ:TXMD) Breakeven?
Simply Wall St. · 06/28 14:41
Hedge Funds Are Dumping TherapeuticsMD Inc (TXMD)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain
Insider Monkey · 06/25 20:49
3 Drug Stocks That Could Soar in 2020
MotleyFool.com · 06/10 14:31
TherapeuticsMD Director Bisaro Buys 50,000 Shares @$1.14/Share
- Form 4
Benzinga · 06/08 20:13
TherapeuticsMD Announces Appointment of James C. DArecca as Chief Financial Officer and Retirement of Daniel A. Cartwright as Chief Financial Officer
Business Wire · 06/01 11:50
TherapeuticsMD Announces James D'Arecca CFO Following Retirement of Current CFO
Benzinga · 06/01 10:52
Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options
Investors need to pay close attention to TherapeuticsMD (TXMD) stock based on the movements in the options market lately.
Zacks · 05/27 13:47
Edited Transcript of TXMD earnings conference call or presentation 6-May-20 12:30pm GMT